Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Biotechnol Adv ; 35(1): 95-104, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28011075

RESUMO

The development of customizable sequence-specific nucleases such as TALENs, ZFNs and the powerful CRISPR/Cas9 system has revolutionized the field of genome editing. The CRISPR/Cas9 system is particularly versatile and has been applied in numerous species representing all branches of life. Regardless of the target organism, all researchers using sequence-specific nucleases face similar challenges: confirmation of the desired on-target mutation and the detection of off-target events. Here, we evaluate the most widely-used methods for the detection of on-target and off-target mutations in terms of workflow, sensitivity, strengths and weaknesses.


Assuntos
Sistemas CRISPR-Cas/genética , Desoxirribonucleases , Edição de Genes/métodos , Mutação/genética , Animais , Sequência de Bases , Linhagem Celular , Desoxirribonucleases/genética , Desoxirribonucleases/metabolismo , Humanos , Camundongos
2.
Plant Biotechnol J ; 14(12): 2203-2216, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27614091

RESUMO

The CRISPR/Cas9 system and related RNA-guided endonucleases can introduce double-strand breaks (DSBs) at specific sites in the genome, allowing the generation of targeted mutations in one or more genes as well as more complex genomic rearrangements. Modifications of the canonical CRISPR/Cas9 system from Streptococcus pyogenes and the introduction of related systems from other bacteria have increased the diversity of genomic sites that can be targeted, providing greater control over the resolution of DSBs, the targeting efficiency (frequency of on-target mutations), the targeting accuracy (likelihood of off-target mutations) and the type of mutations that are induced. Although much is now known about the principles of CRISPR/Cas9 genome editing, the likelihood of different outcomes is species-dependent and there have been few comparative studies looking at the basis of such diversity. Here we critically analyse the activity of CRISPR/Cas9 and related systems in different plant species and compare the outcomes in animals and microbes to draw broad conclusions about the design principles required for effective genome editing in different organisms. These principles will be important for the commercial development of crops, farm animals, animal disease models and novel microbial strains using CRISPR/Cas9 and other genome-editing tools.


Assuntos
Sistemas CRISPR-Cas/genética , Endonucleases/genética , Endonucleases/metabolismo , Animais , Edição de Genes , Humanos , Mutagênese Sítio-Dirigida , Mutação/genética , Edição de RNA/genética
3.
Biotechnol J ; 11(1): 107-16, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26632507

RESUMO

The commercial development of plant-based antibody production platforms is often limited by low and variable yields, but little is known about the factors that affect antibody accumulation during and after translation. Here, we present a strategy to identify yield-limiting regions in the transcript and protein. We exchanged variable heavy chain (VH) domain sequences between two human antibodies at structurally conserved positions, thus creating ten chimeric VH domains containing sequences from M12 (∼1000 µg/g leaf fresh weight [FW]) and 4E10 (∼100 µg/g FW). After transient expression in Nicotiana benthamiana leaves, we measured mRNA and protein levels by quantitative real-time PCR and surface plasmon resonance spectroscopy, respectively. Transcript levels were similar for all constructs, but antibody levels ranged from ∼250 µg/g to over 2000 µg/g FW. Analysis of the expression levels showed that: i) 4E10 yields were only marginally increased by suppression of post-transcriptional gene silencing; ii) the CDR3 of 4E10 contains a protease site; and iii) a bipartite, yield-limiting region exists in the CDR2/CDR3. Our findings highlight the strong impact of cotranslational and posttranslational events on antibody yields and show that protein engineering is a powerful tool that can be used to overcome the remaining limitations affecting antibody production in plants.


Assuntos
Anticorpos/isolamento & purificação , Nicotiana/genética , Anticorpos de Domínio Único/genética , Anticorpos/genética , Folhas de Planta/genética , Plantas Geneticamente Modificadas/metabolismo , Engenharia de Proteínas/métodos , Ressonância de Plasmônio de Superfície , Nicotiana/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA